Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

66.14%

64.90%

66.15%

66.15%

Annual Dental Visits (ADV) Total

45.69%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

66.20%

46.74%

48.16%

48.16%

Appropriate Testing for Pharyngitis (CWP)

58.85%

77.56%

69.03%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

88.19%

93.08%

85.18%

91.27%

Asthma Medication Ratio (AMR) Total

55.51%

69.41%

57.57%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

51.01%

66.19%

51.90%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

67.64%

68.61%

69.59%

71.78%

Breast Cancer Screening (BCS)

53.48%

55.25%

Breast Cancer Screening (BCS-E)

53.34%

54.94%

55.49%

56.66%

Cervical Cancer Screening (CCS)

59.37%

59.85%

58.04%

60.10%

Childhood Immunization Status (CIS) Combination #10

23.84%

35.04%

22.63%

31.32%

Chlamydia Screening in Women (CHL) Total

64.89%

61.07%

65.51%

61.46%

Controlling High Blood Pressure (CBP)

63.26%

65.45%

61.72%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

81.31%

80.86%

84.45%

83.51%

Eye Exam for Patients With Diabetes (EED)

53.53%

56.20%

53.53%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

NB

27.73%

NB

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

21.97%

46.35%

21.15%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

NB

41.03%

NB

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

NB

37.31%

NB

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

56.28%

57.90%

58.37%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

58.37%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

50.61%

55.72%

56.93%

59.64%

Immunizations for Adolescents (IMA) Combination #2

29.88%

38.93%

36.25%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

NB

16.94%

NB

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

29.07%

38.80%

36.46%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

27.33%

39.01%

31.02%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

31.02%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

27.07%

31.93%

23.36%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

70.76%

75.79%

70.44%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

87.58%

86.96%

86.69%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

91.45%

≤ 92.72%

86.66%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

81.02%

86.86%

84.50%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

71.53%

80.78%

73.39%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

11.37%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

11.37%

25.81%

11.48%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

5.97%

≤ 2.45%

5.73%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

81.57%

81.64%

81.16%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

71.96%

73.63%

73.66%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

69.95%

67.07%

69.53%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

69.99%

70.37%

69.60%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

64.64%

63.89%

68.45%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

76.65%

75.44%

70.88%

72.74%

Use of Opioids at High Dosage (HDO)

1.40%

≤ 2.19%

1.12%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

1.34%

≤ 0.87%

1.85%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

78.10%

83.21%

84.44%

86.20%